Business · 09/04/2007Updated: 10/17/2026 · 1 min read
FDA Releases Draft Guidance on Adverse Event Reporting for Human Subject Protection
Summary
The FDA has released a draft guidance to help the research community better report adverse events to protect human subjects, addressing concerns about the volume of reports hindering IRB protection.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →